ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor. - Wikidata - wikimedia - TriplyDB

ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor.

ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor.

http://www.wikidata.org/entity/Q36710981

about

Molecular aspects of prostate cancer with neuroendocrine differentiation Evolution of the cancer genome N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data.ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin The HOPE fixation technique--a promising alternative to common prostate cancer biobanking approaches.Advancing a clinically relevant perspective of the clonal nature of cancer Histone modifications are associated with transcript isoform diversity in normal and cancer cells The role of HOXC6 in prostate cancer development.Personalized management in low-risk prostate cancer: the role of biomarkers.SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer.Nucleotide resolution analysis of TMPRSS2 and ERG rearrangements in prostate cancer.Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma.Comprehensive analysis of the transcriptional profile of the Mediator complex across human cancer types.Diagnostic and prognostic molecular biomarkers for prostate cancer.ERG protein expression as a biomarker of prostate cancer.Small cell carcinoma of the prostate.Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer.Liquid biopsy: ready to guide therapy in advanced prostate cancer?Staurosporine analogs promote distinct patterns of process outgrowth and polyploidy in small cell lung carcinoma cells.In situ sequencing identifies TMPRSS2-ERG fusion transcripts, somatic point mutations and gene expression levels in prostate cancers.The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer.Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.Ecotropic viral integration site 1, a novel oncogene in prostate cancer.Potential for targeted therapy in prostate cancers with ERG abnormalities.ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies.Deletion of Interstitial Genes between TMPRSS2 and ERG Promotes Prostate Cancer Progression.TMPRSS2-ERG gene fusion in Turkish patients with localized prostate cancer: results of radical prostatectomy specimens ERG gene rearrangements are common in prostatic small cell carcinomas.Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas.ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer.Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma.Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course.Prognostic significance of phospho-histone H3 in prostate carcinoma.ERG expression and prostatic adenocarcinoma.Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.Prognostic significance of YWHAZ expression in localized prostate cancer.Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancer Sarcomatoid carcinoma of the prostate:ERGfluorescencein-situhybridization confirms epithelial origin

P2860

Q26752910-AE1B0646-30C4-4951-BD0C-A43F1D345BCE Q28678232-8C59D228-E28A-423C-AD40-2E5E9DD5906E Q28771715-F3FB351E-FB7C-4921-A4EB-AD07F5E50B55 Q30887494-3431D719-2700-42A6-933B-B511A019FF77 Q31005436-60216850-49F3-4877-AB11-F28F2507707D Q34093988-5D999F3E-FD3A-437B-B7E3-850376422858 Q35123202-0F10274B-6393-4816-BF2C-E841DC50D0FD Q35182079-2A767E9A-2617-4796-8442-58411D322C98 Q35756663-9D53B204-49E1-431F-9A9A-7603EBEF4196 Q36495701-598B4CBE-983A-4DC9-8CBD-108AB98D6E9D Q36688923-950BA2F8-6EC6-4741-86B3-DCB2C19A5171 Q36888450-2A2FFC3E-99C2-4FF8-9F5D-4E7D47FBC91A Q36901964-14E23135-6761-447F-93C6-F99E40F4CB8F Q37268937-5E827247-CE4F-4960-B16E-44FD631E097C Q37972703-298279D9-F7D7-4802-AA0B-DA8B28CD986F Q38165243-52F6AE2C-13C5-4037-99E6-1D3056426D9C Q38188869-B6B10C87-2B14-4E95-A952-86D6E0C3E332 Q38322114-D66EEB75-61FC-415A-86C7-2DA3F93263C6 Q38391360-DB6C8C1C-1EFC-4547-AA01-D8267ADC0A5A Q38840458-8E152A4A-97D1-4A45-94CE-D9462AF08389 Q38930827-6E74B3A5-4864-4458-9D90-D4746858C48C Q39175666-F299D1A9-09EB-4949-A108-8513E10B3656 Q39182339-295D89C0-9A84-4049-B52A-2A1D9E9C5075 Q39385550-BAEDF30A-A036-4B2F-9AAB-F29A81FCA2FA Q39401617-81593616-98C8-45B5-B790-8FC46488BB82 Q39501622-3095EC45-C3CF-4120-9070-E726463972BE Q39666134-9414BC50-2D54-416B-8F1C-67D9AE429162 Q40908009-69B9A05D-ADB1-4D8C-80DE-7A3F0AB7FBEB Q41052383-593424D1-11CA-453F-BED4-3CBD02FB4B5B Q41628946-04B003D6-4D8B-4D67-A530-81083C31D88C Q42350997-CECFB7B4-FCC0-4BB2-899D-126C13FA7530 Q43247408-CF85D99E-0055-458F-96AF-E4B1005B1AEE Q45968823-A904D435-716A-4B59-B402-4C47DC234DDE Q47355331-57E24BF0-0EDA-4B61-82EC-445732A7D6A7 Q47931762-A155FB81-39CD-4B91-89EE-7D8A6870A0A2 Q50964849-E7351294-C47F-49E1-B7A5-17E14F0D675E Q53628430-0556B67F-4BDD-40F0-92AA-16BBEB089D23 Q55058481-A1ACEBC0-C27C-40E6-8E03-0E78BD38C330 Q57693358-172CA643-1317-4A9E-811A-B804D108A82E Q57693868-C9022388-5E2D-414A-A15A-C0E58C9CEC9F

P2860

ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor.

http://www.wikidata.org/entity/Q36710981

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

ERG rearrangement is specific ...... cur in any other common tumor.

@ast

ERG rearrangement is specific ...... cur in any other common tumor.

@en

type

label

ERG rearrangement is specific ...... cur in any other common tumor.

@ast

ERG rearrangement is specific ...... cur in any other common tumor.

@en

prefLabel

ERG rearrangement is specific ...... cur in any other common tumor.

@ast

ERG rearrangement is specific ...... cur in any other common tumor.

@en

P1433

Q36710981-4E8C9222-EB21-43EF-9A4E-2A0139EF323E

P1476

Q36710981-DB1F675A-B799-4376-A2E7-58C61DB1997A

P2093

Q36710981-11490017-3491-4B06-8522-C745EDBA5D60

Q36710981-38107036-7736-4970-9254-9EF7818902AA

Q36710981-50A04301-8D08-4143-A5C3-5F0F2DA7BFB1

Q36710981-50F56F38-AB24-49A7-9AE7-212A2C787A91

Q36710981-638938A1-8B98-4CFA-A68E-BF112A7D89BF

Q36710981-6BFABE67-F6A8-4E39-BB0A-980D810B7DD0

Q36710981-812945E6-3F6C-40C1-B098-5D1179C955B6

Q36710981-86AA3CC4-3D20-42C9-A5FB-1230AE388A42

Q36710981-BD93BB39-99CC-4BDB-A086-86411C9AB24B

Q36710981-C3E3C4D4-BC47-484D-9002-A7CC69741B10

P2860

Q36710981-0801ACF4-B52C-4F74-A951-A274E3D08CD4

Q36710981-0A53C8C4-BE7A-4737-AC14-E6A5C70E7267

Q36710981-202135F6-1140-4823-986B-952FF7E2CA5B

Q36710981-25F71C53-1357-4844-9B8C-E5D35A1225BC

Q36710981-33303880-4A93-40D2-9B8C-BA4E581B0DDF

Q36710981-36520F84-3214-4BBB-AADC-D88CCE1049A1

Q36710981-3B3D4B99-ACF4-4512-8ABC-8533CE5C0E96

Q36710981-41713FEE-D11E-4012-9DCF-C932F0FB3E78

Q36710981-63A26C83-E41A-4DCA-85BB-56B804F75C46

Q36710981-648AB070-1590-4C90-8828-3256F36F3F43

P2888

Q36710981-62DF5EA0-D586-4122-9CDB-78332227BD3D

P304

Q36710981-FB19F0C1-E4AF-473A-B09A-4857D437625F

P31

Q36710981-D203ED9C-5D4A-4222-94D7-3A3D8A44E22F

P356

Q36710981-C6995679-8F47-489A-A234-6460A5936B4C

P433

Q36710981-FD571952-C7B5-44A4-978C-D87F1C5B83AE

P478

Q36710981-2F9B1FC4-857B-4FF2-87AF-52A0DAD0024A

P50

Q36710981-00D876E7-BE1F-4CE3-92A7-7B59B3FFE9FA

Q36710981-247C0403-8779-49AD-896F-2C4A91BBC938

Q36710981-37B09FDB-5AA1-4C6C-9675-80969663DA0A

Q36710981-9FA96098-E4B1-4202-8B09-178A0BD539CB

P577

Q36710981-789F5291-6AE2-4E6D-BD3D-D36D0A55EADB

P5875

Q36710981-BE3CFA5E-D333-4336-9D7A-168CCEA63BBC

P698

Q36710981-011051D2-0990-4E1E-80ED-4A958247FC56

P932

Q36710981-1F0480B8-51F9-42E4-B47C-F14AC7FB485F

P356

MODPATHOL.2010.87

P1433

Modern Pathology

P1476

ERG rearrangement is specific ...... cur in any other common tumor.

@en

P2093

Ann-Cathrin Stiedl

http://www.w3.org/2001/XMLSchema#string

Christian Ruiz

http://www.w3.org/2001/XMLSchema#string

David Schilling

http://www.w3.org/2001/XMLSchema#string

Glen Kristiansen

http://www.w3.org/2001/XMLSchema#string

Karen Petersen

http://www.w3.org/2001/XMLSchema#string

Lukas Bubendorf

http://www.w3.org/2001/XMLSchema#string

Markus Reischl

http://www.w3.org/2001/XMLSchema#string

Martin Braun

http://www.w3.org/2001/XMLSchema#string

Rainer Kuefer

http://www.w3.org/2001/XMLSchema#string

Rameen Beroukhim

http://www.w3.org/2001/XMLSchema#string

P2860

Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement

TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Comprehensive mapping of long-range interactions reveals folding principles of the human genome

The landscape of somatic copy-number alteration across human cancers.

Recurrent fusion oncogenes in carcinomas.

Induced chromosomal proximity and gene fusions in prostate cancer.

EML4-ALK fusion lung cancer: a rare acquired event.

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer.

The impact of translocations and gene fusions on cancer causation.

P2888

modpathol.2010.87

P304

1061-1067

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2010.87

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Matthew Meyerson

P577

2010-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44602463

http://www.w3.org/2001/XMLSchema#string

P698

20473283

http://www.w3.org/2001/XMLSchema#string

P932

3606550

http://www.w3.org/2001/XMLSchema#string